Seidegård J, DePierre J W, Guenthner T M, Oesch F
Eur J Biochem. 1986 Sep 1;159(2):415-23. doi: 10.1111/j.1432-1033.1986.tb09884.x.
The influence of metyrapone, chalcone epoxide, benzil and clotrimazole on the activity of microsomal epoxide hydrolase towards styrene oxide, benzo[a]pyrene 4,5-oxide, estroxide and androstene oxide was investigated. The studies were performed using liver microsomes from rats, rabbits, mice and humans; epoxide hydrolase purified from rat liver microsomes to apparent homogeneity; and the purified enzyme incorporated into liposomes composed of egg-yolk phosphatidylcholine or total rat liver microsomal lipids. All four effectors were found to activate the hydrolysis of styrene oxide by epoxide hydrolase in situ in rat liver microsomal membranes, in agreement with earlier findings. Epoxide hydrolase activity towards styrene oxide in liver microsomes from mouse, rabbit and man was also increased by all four effectors. The most striking effect was a 680% activation by clotrimazole in rat liver microsomes. However, none of the effectors activated microsomal epoxide hydrolase more than 50% when benzo[a]pyrene 4,5-oxide, estroxide or androstene oxide was used as substrate. Indeed, clotrimazole was found to inhibit microsomal epoxide hydrolase activity towards estroxide 30-50% and towards androstene oxide 60-90%. The effects of these four compounds were found to be virtually identical in the preparations from rats, rabbits, mice and humans. The effects of metyrapone, chalcone epoxide, benzil and clotrimazole on purified epoxide hydrolase were qualitatively the same as those on epoxide hydrolase in intact microsomes, but much smaller in magnitude. These effects were increased in magnitude only slightly by incorporation of the purified enzyme into liposomes made from egg-yolk phosphatidylcholine. However, when incorporation into liposomes composed of total microsomal lipids was performed, the effects seen were essentially of the same magnitude as with intact microsomes. When the extent of activation was plotted against effector concentration, three different patterns were found with different effectors. Activation of epoxide hydrolase activity towards styrene oxide by clotrimazole was found to be uncompetitive with the substrate and highly structure specific. On the other hand, inhibition of epoxide hydrolase activity towards androstene oxide by clotrimazole was found to be competitive in microsomes. It is concluded that the marked effects of these four modulators on microsomal epoxide hydrolase activity are due to an interaction with the enzyme protein itself, but that the presence of total microsomal phospholipids allows the maximal expression leading to similar degrees of modulation as those observed in intact microsomes.(ABSTRACT TRUNCATED AT 400 WORDS)
研究了甲吡酮、查耳酮环氧化物、联苯甲酰和克霉唑对微粒体环氧化物水解酶催化环氧苯乙烯、苯并[a]芘4,5-环氧化物、雌酮环氧化物和雄烯环氧化物活性的影响。研究使用了来自大鼠、兔子、小鼠和人类的肝微粒体;从大鼠肝微粒体中纯化至表观均一的环氧化物水解酶;以及掺入由蛋黄磷脂酰胆碱或大鼠肝微粒体总脂质组成的脂质体中的纯化酶。与早期研究结果一致,发现所有这四种效应物均可在大鼠肝微粒体膜中原位激活环氧化物水解酶对环氧苯乙烯的水解作用。所有这四种效应物也均可提高小鼠、兔子和人类肝微粒体中环氧化物水解酶对环氧苯乙烯的活性。最显著的效应是克霉唑在大鼠肝微粒体中产生680%的激活作用。然而,当以苯并[a]芘4,5-环氧化物雌酮环氧化物或雄烯环氧化物作为底物时,没有一种效应物能激活微粒体环氧化物水解酶超过50%。实际上,发现克霉唑可抑制微粒体环氧化物水解酶对雌酮环氧化物的活性30%-50%,对雄烯环氧化物的活性60%-90%。发现这四种化合物在大鼠、兔子、小鼠和人类的制剂中的作用几乎相同。甲吡酮、查耳酮环氧化物、联苯甲酰和克霉唑对纯化的环氧化物水解酶的作用在性质上与对完整微粒体中环氧化物水解酶的作用相同,但程度要小得多。将纯化酶掺入由蛋黄磷脂酰胆碱制成的脂质体中,这些作用仅略有增强。然而,当掺入由微粒体总脂质组成的脂质体中时,观察到的作用基本上与完整微粒体中的作用程度相同。当将激活程度与效应物浓度作图时,发现不同效应物呈现三种不同模式。发现克霉唑对环氧化物水解酶催化环氧苯乙烯活性的激活作用与底物呈非竞争性且具有高度结构特异性。另一方面,发现克霉唑对微粒体中环氧化物水解酶催化雄烯环氧化物活性的抑制作用具有竞争性。得出结论,这四种调节剂对微粒体环氧化物水解酶活性的显著作用是由于与酶蛋白本身的相互作用,但微粒体总磷脂的存在可使这种作用达到最大程度的表达,从而导致与在完整微粒体中观察到的调节程度相似。(摘要截选至400字)